The term “type 3 diabetes” results from a conjunction of the pathological mechanisms observed in diabetes and Alzheimer’s disease, primarily insulin resistance, persistent hyperglycemia, and cognitive deficits. This evidence concerns the gene INS and diabetes mellitus.